Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series

KOYUNCU A., Celebi F., Ertekin E., Kok B. E., Tukel R.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, vol.7, no.11, pp.241-247, 2017 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 11
  • Publication Date: 2017
  • Doi Number: 10.1177/2045125317714193
  • Journal Name: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), EMBASE, Directory of Open Access Journals
  • Page Numbers: pp.241-247
  • Keywords: attention-deficit/hyperactivity disorder, comorbidity, extended-release methylphenidate, social anxiety disorder, treatment, DEFICIT HYPERACTIVITY DISORDER, AGE-DEPENDENT DECLINE, PSYCHIATRIC COMORBIDITY, ATOMOXETINE TREATMENT, CONTROLLED-TRIAL, ADHD, CHILDREN, PREVALENCE, PHOBIA, PREDICTORS
  • Istanbul University Affiliated: Yes

Abstract

Background: The relationship between social anxiety disorder (SAD) and attention-deficit/hyperactivity disorder (ADHD) is a subject which has recently become a topic of interest for research.